Pressure immobilization (PI) has been used as a first-aid technique to slow the central movement of snake venom, particularly after bites by neurotoxic snakes such as Australian elapids. Pressure immobilization is completed by wrapping the entire extremity with a compression bandage starting at the bite site and then splinting the extremity for transport. The technique is not yet suggested for snakebites causing severe local tissue destruction, such as the American crotalids.
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This study was a randomized, controlled trial using 20 anesthetized, laboratory pigs. All 20 pigs were randomized to receive 20 mg/kg of western diamondback rattlesnake (Crotalus atrox) venom injected intramuscularly into their hind legs. Ten pigs were then placed in PI splints 1 minute after envenomation and 10 had no PI. Variables measured included time to death, intracompartmental pressures before and after envenomation, and leg circumference.
The dose of venom used in this study had 100% mortality. One pig in the control group died immediately after receiving venom and had to be removed from the study. The median survival time was significantly longer in the PI group (191 minutes) vs the control group (155 minutes) with a P ϭ .0122. The mean intracompartmental pressure in the PI group was 67 mm Hg and was 24 mm Hg in the control group. Leg circumference was 14 cm with PI and 19 cm in the control group. There was no evaluation using a smaller, less lethal envenomation.
Median time of death in this study was delayed by 23% in the PI group. The same group also had increased intracompartmental pressures but less extremity swelling than the control group. The application of the PI splint increased the intracompartmental pressures in the experimental group to a potentially surgical level that could require fasciotomy and increased morbidity. The study data suggest that PI can improve survival times, but may increase local damage in the affected extremity. While PI could be life-saving in potentially fatal envenomations, its role in less severe envenomations or for snakebites causing only local tissue destruction is still unclear. (Ann Emerg Med. 2004; 44:599-604 Adventure racing is a fairly new sport in which participants race in multiple events including climbing, flat and white-water boating, trail running, mountain biking, mountaineering, and various other extreme sports. Teams usually consist of multiple members, and races range from 24 hours to over a week in length. Since this sport is fairly new, there is little information on the types of injuries or medical problems encountered during these events.
This was a prospective cohort study completed during the Subaru Primal Quest Adventure Race that occurred in Washington State from July 7 to 16, 2002 . Eligible individuals included event participants, race staff, support crew, and media totaling 671 subjects. Medical staff included physicians, nurses, paramedics, emergency medical technicians, and physician assistants, and each medical encounter was recorded. Medical encounters included demographics, clinical course, presumptive diagnosis, and disposition. Any encounters that led to withdrawal from the race were specifically recorded.
Medical personnel noted 243 medical encounters and recorded 302 different injuries and complaints. All individuals seen were race participants, crew members, or staff. Injuries made up 59% of diagnoses and illnesses made up 41%. Illnesses included altitude illness, dehydration, gastrointestinal, and respiratory problems. Injuries included blisters, lacerations, abrasions/contusions, and orthopedic injuries. One third of all people treated were diagnosed with foot blisters. Respiratory illnesses were the No. 1 cause of participants withdrawing from the race.
Although this study is taken from a small sample and has no control group, it does provide information that may be used in planning a similar type of event in the future. Although skin and soft tissue injuries can be expected during an endurance race, the high number of respiratory complaints was unforeseen. The distribution of complaints may allow for medical directors of future extreme events to have more blister paraphernalia on hand to allow racers to continue, as well as more respiratory supplies such as metered dose inhalers, nebulizers, and medications such as antibiotics and oral steroids. Additional studies, even observational studies, may help additional protocols to be developed for future adventure races. 
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Acute Mountain Sickness Is Related to Nocturnal Hypoxemia but Not to Hypoventilation
Acute mountain sickness (AMS) commonly occurs after rapid ascent to altitudes above 2500 to 3000 m and presents with headaches, poor appetite, insomnia, dizziness, and nausea. The source of AMS has long been hypothesized to be hypoxia, combined with hypoventilation and periodic breathing that occur during sleep at altitude. Although the role of hypoxia has been proven in many studies, little objective evidence has been published in defense of the hypoventilation hypothesis, as sleep studies are difficult to achieve in the harsh environment of high altitude. In this study, European scientists elected to use calibrated respiratory inductive plethysmography to monitor nocturnal ventilation and periods of apnea/hypopnea in mountaineers at altitude and found that their techniques were well tolerated using unobtrusive equipment in the relative comfort of a mountain hut.
Twenty-five mountaineers were recruited as they ascended from 1170 m to a mountain hut on Mt Rosa in Italy located at 3610 m. All recruits then ascended to a higher hut at 4559 m where they underwent nocturnal testing of their breathing patterns and ventilation using pulse oximetry and plethysmography. Acute mountain sickness was assessed the morning after the overnight in the hut using standardized Lake Louise scoring.
Twenty-one of the 25 recruits successfully completed the overnight testing (4 individuals had equipment failures and their data were discarded). In the morning, 11 subjects were diagnosed with AMS according to Lake Louise criteria and were designated as the test group, while the remaining 10 with no AMS were classified as the controls. No cases of high altitude pulmonary edema or high altitude cerebral edema were documented. The AMS group was found to have significantly higher rates of nocturnal ventilation, higher inspiratory flow (measurement of central respiratory drive), lower arterial oxygen measurements, and increased rates of night moving (decreased sleep efficiency) compared to controls. Both groups had similar rates of apnea and hypopnea.
Results indicate that the group with diagnosed AMS had preceding hypoxemia, elevated levels of nocturnal ventilation, and significantly more restless sleep compared to controls. These findings go against those previous studies indicating a link between AMS and hypoventilation. Instead, these data suggest that impaired gas exchange is a more important contributor to AMS than is hypoventilation, a suppressed central respiratory center, or periodic breathing. Larger studies would have to be completed to further substantiate these findings. High altitude pulmonary edema (HAPE) is a noncardiac cause of pulmonary edema that typically occurs when individuals ascend to an altitude greater than 2400 m (8000 feet) without appropriate acclimatization. Both human and animal studies have shown that some individuals are more susceptible to HAPE than others. Implicated risk factors have included rapid ascent, obesity, and importantly, those with a previous diagnosis of HAPE. Individuals with a past diagnosis of HAPE have shown an increase in hypoxic response of pulmonary vasoconstriction, increased resting pulmonary vascular resistance, and increased pulmonary arterial pressures with exercise when compared to controls. Recent animal studies have shown that hypoxia can cause increased spatial heterogeneity of pulmonary perfusion and subsequent unevenness of hypoxic vasoconstriction. Areas without protective vasoconstriction could be exposed to increased arterial and capillary pressures, leading to high permeability edema and HAPE.
This study was designed to show a presence or absence of spatial pulmonary heterogeneity in humans, similar to other experimental mammals. Three groups of individuals underwent functional magnetic resonance imaging (MRI) that included arterial spin labeling, allowing for visualization of blood flow and specifically spatial perfusion. The subject groups were as follows: (1) HAPE susceptible, with a documented history of HAPE (n ϭ 5), (2) HAPE resistant, with multiple exposures to extremely high altitudes with no history of HAPE (n ϭ 6), and (3) unselected subjects, with little to no history of exposure to high altitude (n ϭ 6). Each individual underwent arterial spin labeling MRI with 5 measurements: baseline (room air) and after exposure to hypoxia equivalent to 3800 m of altitude for 5, 10, 20, and 30 minutes. An index of blood flow heterogeneity, as well as heart rate and pulse oximetry, was collected at each data point for each individual.
Results of the study showed no significant difference between the 2 groups in heart rate and pulse oximetry, either at baseline or with hypoxia. MRI perfusion maps were completed of all individuals at baseline and with hypoxia. These maps showed no difference between groups in dispersion of signal intensity at baseline. However, with hypoxia, relative dispersion was significantly increased in all HAPE sensitive individuals, indicating increased pulmonary blood flow heterogeneity. In addition, the HAPE sensitive subjects also had an observed negative correlation between oxygen saturation and increased pulmonary blood flow heterogeneity.
This study does show a quantitative difference in pulmonary blood flow heterogeneity in HAPE susceptible individuals. The results could not show whether this difference is a contributor of HAPE or a result of a past insult from HAPE. Scientists have long thought that HAPE was at least partially caused by increased pulmonary vascular pressures, but this study indicates a more complex mechanism of heterogeneous vasoconstriction and increased pulmonary vascular pressures. 
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Severity and Pattern of Injury in Survivors of Alpine Fall Accidents
Accidents during mountaineering are known causes of significant morbidity and mortality, yet little is known about the medical ramifications of falls during alpine activities. Significant research has been completed concerning injury patterns that occur during falls in urban settings, such as suicide attempts or industrial falls; however, there are obvious differences in mechanism when urban falls are compared to mountaineering accidents. These researchers hoped to obtain data that would better allow for appropriate triage and treatment of these types of wilderness victims.
Data were collected via a 2-year review of the emergency medical helicopter records for 3 physician-staffed helicopters in the western Austrian Alps. Patient records were obtained from 117 people, but 20 patients were excluded for being in cardiopulmonary arrest upon arrival of the helicopter. Extricated data included demographics, details of the accident (particularly height) and the rescue (time on scene, requirement for a winch rescue), and discharge diagnoses from the treating hospitals. Injuries were graded using the Abbreviated Injury Scale, and scores were combined to form the Injury Severity Scores (ISSs). The ISSs can range from 0 (no injury) to 75. Critical multisystem trauma is considered to be any number greater than 20.
A total of 97 patients were included in the analysis, of which 87% of falls occurred during recreational activities and 13% occurred while individuals were working. Many accidents and rescues occurred during the afternoon, and rescues were often difficult with prolonged extrications. Seventy-one percent of patients had only mild or moderate injuries (ISS less than or equal to 13), while the remainder were severely or critically injured. Fractures, particularly of the pelvis and extremities, were the most common injury. Rib fractures, almost half of which were associated with pneumothorax, were found in 17 patients. Most spinal fractures (81%) were in the thoracolumbar spine. Cervical spine injuries were rare by comparison (4 patients) as were critical head injuries, with only 6 patients having a Glasgow Coma Scale score less than 9. Only 2% of victims had visceral abdominal injuries. The mean height of falls could be determined using the data from only 68% of victims and was estimated to be 51.4 m. Falls of greater than 50 m had a higher association with critical injuries, such as severe head injuries.
Alpine falls are known to differ from urban falls by mechanism. Typically, alpine falls involve not only a period of free fall, but sliding and tumbling as well. Direct impact, as well as deceleration injuries, results from this type of trauma. Interestingly, this study found very few visceral injuries in victims, but the study only included those patients who survived until rescue and would exclude anyone with a major hemorrhage or a potentially fatal head injury without short-term intervention. Interestingly, the data did show that most of those patients who survived to rescue had fractures that could be immobilized prior to transfer. Other effective prehospital treatments were shown to include spinal immobilization and administration of pain medication. Although the majority of transported patients had only mild to moderate injuries, the still significant number of severely and critically injured patients, combined with the 20 deceased prior to transport, provide evidence that a victim of an alpine fall could benefit from direct transport to a trauma center, where appropriate triage and evaluation can be completed for all patients. 
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New World Mucosal and Cutaneous Leishmaniasis: An Emerging Health Problem Among British Travelers
Leishmaniasis is an infection by the protozoan parasite, Leishmania, and results in 3 types of presentation: visceral, cutaneous, and mucosal leishmaniasis. Although visceral and cutaneous leishmaniasis (CL) commonly appear within weeks to months after infection in an endemic area, mucosal leishmaniasis (ML) may not present for 6 months to a year after the initial infection by the cutaneous form of the disease. Importantly, several virulent species of Leishmaniasis (V. braziliensis, guyanensis, and panamensis) are known to cause the cutaneous and mucosal forms and are endemic in Latin American countries, including Belize, Columbia, and Bolivia. The mucosal form of leishmaniasis occurs when protozoa infect the nasopharyngeal mucosa. The dangerous result is a destructive inflammatory process that may or may not be successfully treated with antibiotics. Early presentations are often misdiagnosed because they may occur months or years after exposure and are often mistaken with sinus or allergic processes. With increased travelers venturing to the endemic areas of Latin America, increased number of cases presenting to emergency departments and primary care providers in Europe and the United States will occur, and it is important that physicians in these nations can recognize the processes.
The authors of this study designed a retrospective, observational study of patients with CL and ML that have presented to the Hospital for Tropical Disease in London between 1995 and 2003. All patients diagnosed and treated for CL and ML were included in the study. Diagnosis was made via clinical evaluation by infectious disease physicians and otorhinolaryngologists, and histologic diagnosis was made via biopsies examined with polymerase chain reaction (PCR). Overseas travel history of the same time period was then examined using data from the International Passenger Survey as part of the Office of National Statistics.
Seventy-nine cases of PCR-positive L. viannia CL were found, with the number of cases diagnosed increasing each year between 1995 and 2003. There was a 3-fold increase in cases in 2002 to 2003 compared to the first 2 years of the study. In comparison, there were 3 times more British citizens traveling to Latin America over the same time period. The positive correlation for annual number of travelers to Latin America and those diagnosed with CL was r ϭ 0.72. Of those patients with CL, 4 individuals were diagnosed with ML. This was in addition to 2 cases of ML with no diagnosis of CL. Each of the 6 cases was detailed within this article, but one similarity of the 6 cases was that all had been backpacking in forested areas of Latin America prior to their diagnosis.
The authors did make several interesting observations from this study, which turned out to be the largest single series of cases of travelers with ML ever reported. Increased numbers of CL and ML seemed to directly correspond to increased travel to endemic areas of Latin America. Some patients with CL that resolved without treatment went on to develop ML, suggesting that all patients diagnosed with CL should be treated empirically, even if cutaneous lesions appear to be resolving prior to antibiotic treatment. ML is difficult to treat, even with parenteral antibiotics, and thus should be prevented if possible. Finally, if CL and/or ML are suspected, PCR should be used to definitively diagnosis the disease. (QJM. 2004; 97:781-788 
